AU2003239797A1 - Active substance mixtures of extracts of the genus vaccinium and carotene compounds - Google Patents
Active substance mixtures of extracts of the genus vaccinium and carotene compoundsInfo
- Publication number
- AU2003239797A1 AU2003239797A1 AU2003239797A AU2003239797A AU2003239797A1 AU 2003239797 A1 AU2003239797 A1 AU 2003239797A1 AU 2003239797 A AU2003239797 A AU 2003239797A AU 2003239797 A AU2003239797 A AU 2003239797A AU 2003239797 A1 AU2003239797 A1 AU 2003239797A1
- Authority
- AU
- Australia
- Prior art keywords
- matrix
- chitosan
- production
- active agent
- anionic polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Abstract
The use of an active agent mixture is claimed in the production of a medicament (I) for increasing human power of vision, where the mixture comprises extracts of plants of genus Vaccinium (A) or anthocyanosides and carotene compounds (B). Independent claims are also included for: (1) microcapsules of average diameter 0.1-5 mm, consisting of a shell membrane and a matrix containing the (A)/(B) mixture as active agent, obtained by: preparing a matrix from gel formers, chitosan or an anionic polymer, (A) and (B); optionally dispersing the matrix in an oil phase; and treating the dispersed phase with an aqueous solution of anionic polymer (if the matrix contains chitosan) or chitosan (if the matrix contains anionic polymer) and optionally removing the oil phase; (2) production of the microcapsules (1); (3) pro-liposomal active agent mixtures, obtained by treating (A) and (B) in a solvent with lecithins and/or phospholipids; and (4) production of the mixtures (3).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02008624A EP1354594B1 (en) | 2002-04-17 | 2002-04-17 | Combinations of an extract of a vaccinium type plant and a carotene |
| EP02008624.5 | 2002-04-17 | ||
| PCT/EP2003/003619 WO2003086428A1 (en) | 2002-04-17 | 2003-04-08 | Active substance mixtures of extracts of the genus vaccinium and carotene compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003239797A1 true AU2003239797A1 (en) | 2003-10-27 |
Family
ID=28459478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003239797A Abandoned AU2003239797A1 (en) | 2002-04-17 | 2003-04-08 | Active substance mixtures of extracts of the genus vaccinium and carotene compounds |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1354594B1 (en) |
| AT (1) | ATE392211T1 (en) |
| AU (1) | AU2003239797A1 (en) |
| DE (1) | DE50212104D1 (en) |
| ES (1) | ES2302770T3 (en) |
| WO (1) | WO2003086428A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7566808B2 (en) | 2004-02-17 | 2009-07-28 | President And Fellows Of Harvard College | Management of ophthalmologic disorders, including macular degeneration |
| WO2005079774A2 (en) * | 2004-02-17 | 2005-09-01 | President And Fellows Of Harvard College | Management of ophthalmologic disorders, including macular degeneration |
| CN103142551B (en) * | 2013-04-02 | 2014-08-20 | 黑龙江大学 | Method for preparing micro-capsule by taking xanthan gum and gelatine as wall materials through complex coacervation method |
| CN107668755B (en) * | 2017-09-25 | 2019-07-09 | 山东健源生物科技有限公司 | A kind of preparation method of anti-oxidant microencapsulation material |
| FR3105790B1 (en) * | 2019-12-26 | 2022-01-14 | Biophytis | Chemical compounds targeting the eye and their use in the treatment of ocular diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5955102A (en) * | 1998-09-04 | 1999-09-21 | Amway Corporation | Softgel capsule containing DHA and antioxidants |
| US6103756A (en) * | 1999-08-11 | 2000-08-15 | Vitacost Inc. | Ocular orally ingested composition for prevention and treatment of individuals |
| AU2001256855A1 (en) * | 2000-05-08 | 2001-11-20 | N.V. Nutricia | Preparation for the prevention and treatment of ocular disorders |
| EP1299112A2 (en) * | 2000-06-01 | 2003-04-09 | Theralife, Inc. | Compositions for treating eye discomfort, containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
-
2002
- 2002-04-17 ES ES02008624T patent/ES2302770T3/en not_active Expired - Lifetime
- 2002-04-17 AT AT02008624T patent/ATE392211T1/en not_active IP Right Cessation
- 2002-04-17 EP EP02008624A patent/EP1354594B1/en not_active Expired - Lifetime
- 2002-04-17 DE DE50212104T patent/DE50212104D1/en not_active Expired - Fee Related
-
2003
- 2003-04-08 WO PCT/EP2003/003619 patent/WO2003086428A1/en not_active Application Discontinuation
- 2003-04-08 AU AU2003239797A patent/AU2003239797A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003086428A1 (en) | 2003-10-23 |
| DE50212104D1 (en) | 2008-05-29 |
| ATE392211T1 (en) | 2008-05-15 |
| EP1354594A1 (en) | 2003-10-22 |
| EP1354594B1 (en) | 2008-04-16 |
| ES2302770T3 (en) | 2008-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005535566A5 (en) | ||
| WO2001001929A3 (en) | Microcapsules iv | |
| WO2005018794A8 (en) | Microcapsules | |
| CA2119610A1 (en) | Process for the preparation of a liposome dispersion under elevated pressure conditions | |
| AU6265000A (en) | Microcapsules - iii | |
| EP1022020A3 (en) | Sustained-release preparation | |
| ATE213164T1 (en) | USE OF NONA- AND DECAPEPTIDES FOR PRODUCING A MEDICINAL PRODUCT TO FIGHT AIDS | |
| CA2438097A1 (en) | Cannabinoids pharmaceutical formulations | |
| CA2243201A1 (en) | Process for producing sustained-release preparation | |
| EP1334728A3 (en) | Antithrombotic agents | |
| MXPA05008489A (en) | Manufacturing process for liposomal preparations. | |
| AU2003301747A1 (en) | Pharmaceutical compositions suitable for the treatment of ophthalmic diseases | |
| GB2456976A (en) | System and process for producing a low suspended solids solution and uses therefore | |
| WO2003074086A1 (en) | Liquid matrix undergoing phase transfer in vivo and liquid oral preparations | |
| ATE286430T1 (en) | NANOCAPSULES | |
| WO2000037422A3 (en) | Ion channel modulating agents | |
| AU2003227655A8 (en) | Use of active ingredient mixtures with azelaic acids and glycyrrhetic acids as anti-acne agents | |
| AU2003239797A1 (en) | Active substance mixtures of extracts of the genus vaccinium and carotene compounds | |
| AR024564A1 (en) | COMPOSITION THAT INCLUDES SPPHINGOMYELINASE FOR USE AS A DIETARY PREPARATION, DIETARY SUPPLEMENT OR PHARMACEUTICAL PRODUCT | |
| AU2001291792A1 (en) | Cosmetic preparations | |
| WO2004017943A3 (en) | Non-vesicular cationic lipid formulations | |
| ATE288318T1 (en) | MICRO CAPSULES (VIII) | |
| WO2002053149A3 (en) | Medicament containing a polyamine as an active substance | |
| WO2000067723A3 (en) | Form of administration for applying in body orifices | |
| AU2003227651A1 (en) | Micro-capsules with anti-acne active ingredients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |